Lawver Teri L 4
4 · Celldex Therapeutics, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Lawver Teri L
SVP & Chief Commercial Officer
Transactions
- Award
ISO (right to buy)
2025-11-10+100,000→ 100,000 totalExercise: $22.67From: 2026-11-10Exp: 2035-11-10→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on November 10, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.